Sign in
4

Changes in Ownership

AbbVie Inc. Filed Acc 0002004979-26-000002

EVP, R&D and CSO acquired 18,137 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Thakkar Roopal EVP, R&D and CSO 2026-02-18 Grant or award +6,015 48,291 D: show line 1 in the form
Thakkar Roopal EVP, R&D and CSO 2026-02-18 Grant or award +2,138 50,429 D: show line 2 in the form
Thakkar Roopal EVP, R&D and CSO 2026-02-18 Grant or award +3,346 53,775 D: show line 3 in the form
Thakkar Roopal EVP, R&D and CSO 2026-02-18 Grant or award +6,638 60,413 D: show line 4 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Thakkar Roopal EVP, R&D and CSO 2026-02-18 Grant or award · Option (Right to buy) +21,937 21,937 D: show line 5 in the form
Loading xslF345X05/form4-02202026_110244.xml…